17:05

OI Guidelines Update

16:56

HIV Guideline Update: Antiretroviral Therapy

22:33

Anal Cancer Screening

31:08

Antipsychotics for the HIV Primary Care Provider

25:01

OI Guidelines and Pregnancy Considerations: Updates on Tuberculosis, Syphilis, and Mpox

20:43

Alcohol Use Among People with HIV

17:10

2024 IAS Conference Review

21:35

Primary Care for People Engaged in Sex Work

22:28

Changes to Federal Regulations For Opioid Treatment Programs: Part 2

18:18

Changes to Federal Regulations For Opioid Treatment Programs: Part 1

20:04

Do Integrase Inhibitors or TAF Cause Weight Gain?

14:03

Heart Failure and HIV

26:22

Updates in Mpox

17:09

Guideline Update: Statins for Primary Prevention of Cardiovascular Disease for Persons with HIV

15:53

HIV Pre-Exposure Prophylaxis (PrEP) Medication Monitoring

18:56

Event-driven HIV and STI Prevention for People Assigned Female Sex at Birth

26:01

ART in Renal Failure

21:33

HIV Sepsis Imposters

11:52

HHS Perinatal Guidelines Update

22:20

CROI 2024 Report Back: Treatment Updates

13:10

CROI 2024 Update: Prevention

16:47

CROI 2024 Update: Co-Occurring Conditions

09:54

Introducing NASTAD's Updated PrEP, PEP, & Other HIV Prevention Strategies: Billing and Coding Guide

17:52

Practical Approaches to Polypharmacy

27:39

HIV & The Treatment of Depression III: Antidepressant Selection Part 2

27:39

HIV & The Treatment of Depression II: Antidepressant Selection Part 1

15:53

HIV Pre-Exposure Prophylaxis (PrEP) Quantitative HIV RNA Testing

25:12

Treatment of Obesity

15:54

The REPRIEVE Trial: Practice Changing or Practice Affirming?

30:17

Smoking Cessation in People with HIV

25:30

Addressing the Increased Risk of Lung Cancer in People with HIV

14:48

HIV Pre-Exposure Prophylaxis (PrEP): The Future of PrEP

29:34

HIV & The Treatment of Depression

15:49

Expansion of Pharmacy-Delivered PrEP

18:18

A Race Conscious Approach to Serious Illness

21:16

Fentanyl Updates

20:46

Buprenorphine for Opioid Use Disorder

29:19

Long Term HIV Survivorship and Aging

29:18

Immune Reconstitution Syndrome 2023 - Part 2

23:20

Updates to Testing and Prophylaxis for Infants with HIV Exposure

16:16

More Than The Words We Say: Communicating Through Identity, Stigma, and Trauma

19:01

Hepatitis B in HIV: Augmenting Therapy and HCC Screening

15:28

Pneumococcal Vaccination in People with HIV

15:30

Risk of HIV Transmission with Low Levels of Viremia

32:46

Tacoma MAX Clinic: Low Barrier Approach Through Community Partnerships

16:48

Data Privacy, Community Trust, and HIV Criminalization

28:14

Immune Reconstitution Syndrome, 2023: Part 1 of 2

16:26

Gender Affirming Care for People with HIV: Creating a Safe and Welcoming Environment

18:41

Gender Affirming Care for Persons with HIV: Estrogen & Androgen Blocker Use

16:32

Gender Affirming Care for PWH: Intro & Testosterone Use in Transgender & Gender Diverse Individuals

17:30

PrEP for HIV Prevention: Adherence to PrEP Testing Guidelines in the U.S.

30:38

Doxy-PEP for STI Prevention: Rationale, Results & Next Steps

17:25

HBV Prevention: New Vaccines and the Boundaries of HBV Protection

19:50

Management of HCV and HIV Coinfection

17:34

Impact of ART Initiation in Acute and Early HIV Results from the Sabes Study in Peru

27:01

HIV Drug Resistance Testing Basics

18:35

PrEP for HIV Prevention: PrEP for Transgender Patients

18:06

CROI 2023 Update: Treatment Innovations and ACTG Studies

23:32

CROI 2023: HIV Prevention Updates

20:52

New Recommendations for Infant Feeding & Prevention of Pediatric HIV in the US: What & Why Now?